Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Adults | 1 |
| Aggression | 1 |
| Behavior Disorders | 1 |
| Body Weight | 1 |
| Children | 1 |
| Drug Therapy | 1 |
| Measures (Individuals) | 1 |
| Mental Retardation | 1 |
| Pervasive Developmental… | 1 |
| Pharmacology | 1 |
| More ▼ | |
Source
| Journal of Autism and… | 1 |
Author
| Fleming, Kandace K. | 1 |
| Hellings, Jessica A. | 1 |
| Marquis, Janet G. | 1 |
| Reese, R. Matthew | 1 |
| Schroeder, Stephen R. | 1 |
| Valdovinos, Maria G. | 1 |
| Zarcone, Jennifer R. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkHellings, Jessica A.; Zarcone, Jennifer R.; Reese, R. Matthew; Valdovinos, Maria G.; Marquis, Janet G.; Fleming, Kandace K.; Schroeder, Stephen R. – Journal of Autism and Developmental Disorders, 2006
Risperidone has shown safety and efficacy for aggressive and destructive behaviors in short-term studies. This longer-duration study includes a broad sample. Forty subjects, aged 8-56 years (mean=22), all with mental retardation and 36 with autism spectrum disorders participated in this 22-week crossover study, with 24 weeks of open maintenance…
Descriptors: Drug Therapy, Mental Retardation, Pervasive Developmental Disorders, Children
